Japan based Eisai Co., Ltd. has announced that it has launched the in-house discovered and developed antiepileptic drug ...
Daewoong Infion Co. has achieved world's first halal certification for animal cells-derived biopharmaceuticals. South K...
Slayback Pharma LLC has announced an agreement with The Everstone Group to invest up to $50 million in Series ...
When launched, Ingelvac CircoFLEX® was the first PCV2 vaccine that could be freshly mixed with an M hyo vaccine...
US based aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines b...
China headquartered Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufact...
Antengene Corporation has announced its appointment of Mr. John Chin, MBA, as Chief Business Officer (CBO). He will be r...
I-Mab Biopharma ("I-Mab"), a global biopharmaceutical company based in China and the United States a...
US based Pulmatrix, Inc., a clinical stage biopharmaceutical company developing innovative inhaled therapies to address ...
BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-t...
China based CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory dru...
Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma has announced that it has entered into a $300 million term l...
GlaxoSmithKline has announced the completion of the divestment of travel vaccines Rabipur (tradename Rabavert in the US)...
Germany headquartered pharmaceutical company PAION AG has announced that its South Korean remimazolam licensee Hana Phar...
Daiichi Sankyo Company has announced that it has launched the antitumor agent bevacizumab BS for intravenous drip infusi...
Oncologie, a biopharmaceutical company with innovative oncology therapeutics supported by a biomarker platform to select...
OBI Pharma, Inc., a Taiwan biopharma company has announced that the U.S. Food and Drug Administration (FD...
Japan based Astellas Pharma Inc. and US headquartered Xyphos Biosciences, Inc. have announced that Astellas has acq...
To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of ...
Gilead Sciences, Inc. and Eisai Co., Ltd. have announced that Gilead Sciences K.K. and Eisai have entered into an agreem...
Mankind Pharmaceuticals Ltd. and Glenmark Pharmaceuticals Ltd. have inked a sub-licensing agreement to co-market&nb...
TRACON Pharmaceuticals, a US based clinical stage biopharmaceutical company focused on the development and commercializa...
SINGAPORE AND DENVER, COLORADO, 20 December 2019 After serving as Chairman since 2012, Dr. Claude Nash will step down b...
Glenmark Pharmaceuticals has announced that Seqirus Pty. Ltd. (Seqirus) has received marketing approval for Ryaltris®...
Astellas Pharma Inc. and Seattle Genetics, Inc. have announced that the U.S. Food and Drug Administration (FD...
